Mind Medicine (MindMed) Inc.

News & Events

Press Releases

In The Media

1. MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference

   Business Wire MAY 13, 2025 7:00 AM EDT
   Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMedȁ...
   READ ARTICLE

2. MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates

   Business Wire MAY 8, 2025 7:00 AM EDT
   --Dosed first patient in Emerge, the first Phase 3 study of MM120 Orally Disintegrating Tablet (O...
   READ ARTICLE

3. MindMed to Report First Quarter 2025 Financial Results on May 8, 2025

   Business Wire APR 24, 2025 7:00 AM EDT
   Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a late-stage clinical ...
   READ ARTICLE

4. MindMed Announces New Employee Inducement Grants

   Business Wire APR 21, 2025 4:01 PM EDT
   Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMedȁ...
   READ ARTICLE

5. MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)

   Business Wire APR 15, 2025 7:00 AM EDT
   - Emerge is the first Phase 3 study of lysergide D-tartrate (LSD) in MDD; primary endpoint will m...
   READ ARTICLE

6. MindMed Announces New Employee Inducement Grants

   Business Wire MAR 24, 2025 4:01 PM EDT
   Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMedȁ...
   READ ARTICLE

7. MindMed Appoints Matt Wiley as Chief Commercial Officer

   Business Wire MAR 17, 2025 7:00 AM EDT
   Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical ...
   READ ARTICLE

8. MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates

   Business Wire MAR 6, 2025 7:00 AM EST
   --First Patients Dosed in Phase 3 Voyage and Panorama studies of MM120 Orally Disintegrating Tabl...
   READ ARTICLE

9. MindMed to Present at Leerink's Global Healthcare Conference 2025

   Business Wire MAR 4, 2025 7:00 AM EST
   Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMedȁ...
   READ ARTICLE

10. MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

    Business Wire FEB 20, 2025 7:00 AM EST
    Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a late-stage clinical ...
    READ ARTICLE